There were 1,730 press releases posted in the last 24 hours and 470,313 in the last 365 days.

Technology Solutions for Late Phase Research: Optimizing Real World Data Assets, New Webinar Hosted by Xtalks

ICON logoICON Commercialisation & Outcomes optimises the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.Click here for high-resolution version

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - April 19, 2017) - Michael Cook, Principal of Epidemiology and Bill Row, Divisional Principal of Real World Evidence both from ICON Commercialisation and Outcomes will outline how technological innovation can be applied to late phase research studies and how the smart application of that technology can enhance use of real world data (RWD) assets. The live event will take place on Monday, May 1, 2017 at 11am EDT (4pm BST/UK).

Attendees will gain valuable insights on:

  • The use of EHR data to conduct protocol feasibility assessments
  • How RWD can be optimized and analyzed using technology to enhance clinical research efficiency and provide the real world evidence (RWE) necessary for stakeholder engagement
  • Technology solution considerations for optimizing RWD assets

Overview

With demand increasing for new and innovative ways to approach Late Phase Research (LPR), technology solutions and access to RWD are at the forefront of creating efficiencies in all stages of study design and implementation. But what steps should you take in study planning to ensure these efficiencies are effectively applied? And how can you partner with CROs to ensure that the secondary and primary data are pulled through the appropriate technology solutions for optimal use?

The enrolment process for clinical trials is notoriously inefficient. Sponsors struggle to identify the best investigator sites and enroll the target number of patients amid competing trials. Part of this inefficiency stems from the traditional recruitment model of relying on selected Key Opinion Leaders (KOLs) to recruit patients. With the right information about how many patients are eligible -- and where they are located -- this model can be turned on its head. EHR data can improve this process dramatically. Our experts will discuss:

  • The use of EHR data to conduct protocol feasibility assessments
  • Efficient site and physician identification, as well as patient identification and enrolment
  • Continued collection of EHR data on enrolled patients for ongoing RWE generation
  • The use of a technology platform to cohesively bring the data together

To learn more about this event visit: Technology Solutions for Late Phase Research: Optimizing Real World Data Assets

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, to private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/4/17/11G136018/Images/ICON_Logo_Mar2017-784c521a7dadaaeeb6c517a9ab1db88c.jpg

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.